Hybridization-based CpG methylation level detection using methyl-CpG-binding domain-fused luciferase.

Area of Science:

• Molecular Biology
• Epigenetics
• Biotechnology

Background:

• Cancer genomes exhibit distinct DNA methylation patterns, including hypermethylation of tumor-suppressor genes and global hypomethylation.
• Accurate detection of DNA methylation is crucial for understanding cancer development and progression.

Purpose of the Study:

• To develop a novel hybridization-based method for detecting CpG methylation levels.
• To utilize methyl-CpG-binding domain-fused firefly luciferase (MBD-Fluc) for quantitative methylation analysis.

Main Methods:

• Developed a method employing methylated probe oligonucleotides to capture target oligonucleotides.
• Utilized MBD-Fluc, which specifically binds to fully methylated double-stranded DNA (dsDNA).
• Quantified CpG methylation levels of SEPT9, BRCA1, and LINE-1 using this platform.

Main Results:

• The MBD-Fluc method accurately detected fully methylated dsDNA, distinguishing it from hemimethylated dsDNA.
• Emission detection signals were unaffected by the methylation state of non-hybridized overhang regions, ensuring accurate target region methylation detection.
• CpG methylation levels of SEPT9, BRCA1, and LINE-1 were successfully quantified.

Conclusions:

• The developed MBD-Fluc platform provides a sensitive and accurate method for quantifying CpG methylation.
• The platform's adaptability suggests potential for detecting other modified DNA bases, expanding its utility in epigenetics research.